PBS boasts four new cancer therapies

One, a new drug to treat chronic lymphocytic leukaemia, is partly the product of Australian research
piles of 100 dollar bills

A drug co-developed by Australians, venetoclax, is now listed on the PBS for chronic lymphocytic leukaemia.

The drug (Venclexta, AbbVie) was added to the PBS on 1 March along with new indications for therapies to treat renal, urothelial and liver cancers.